INHIBITOR OF PROLACTINADOSTINEX||INHIBITOR OF PROLACTINADOSTINEX||0. 5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE
INHIBITOR OF PROLACTINADOSTINEX||INHIBITOR OF PROLACTINADOSTINEX||0. 5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE
24-July-2023
300449000000
1. MEDICINAL PRODUCTS FOR HUMANS CONTAINING ALKALOIDS PACKAGED FOR RETAIL SALE NOT IN AEROSOL PACKAGING. DOSTINEX TABLETS OF 0.5 MG 2 TABLETS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX/1 TABLET CONTAINS CABERGOLINE 0.5 MG/GPFIZER ITALY S.R.
1. MEDICINAL PRODUCTS FOR HUMANS CONTAINING ALKALOIDS PACKAGED FOR RETAIL SALE NOT IN AEROSOL PACKAGING. DOSTINEX TABLETS OF 0.5 MG 2 TABLETS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX/1 TABLET CONTAINS CABERGOLINE 0.5 MG/GPFIZER ITALY S.R.
09-June-2023
300449490000
PROLACTINATE INHIBITORTINEX||PROLACTINATE INHIBITORTINEX|| ||0.5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE
PROLACTINATE INHIBITORTINEX||PROLACTINATE INHIBITORTINEX|| ||0.5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE
02-March-2023
300449490000
PROLACTIN INHIBITORDOSTINEX|| ||0.5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE
PROLACTIN INHIBITORDOSTINEX|| ||0.5MG TABLETS||ACTIVE PRINCIPLE CABERGOLINE FOR HUMAN USE